» Articles » PMID: 32961908

Non-Viral Targeted Nucleic Acid Delivery: Apply Sequences for Optimization

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Sep 23
PMID 32961908
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In nature, genomes have been optimized by the evolution of their nucleic acid sequences. The design of peptide-like carriers as synthetic sequences provides a strategy for optimizing multifunctional targeted nucleic acid delivery in an iterative process. The optimization of sequence-defined nanocarriers differs for different nucleic acid cargos as well as their specific applications. Supramolecular self-assembly enriched the development of a virus-inspired non-viral nucleic acid delivery system. Incorporation of DNA barcodes presents a complementary approach of applying sequences for nanocarrier optimization. This strategy may greatly help to identify nucleic acid carriers that can overcome pharmacological barriers and facilitate targeted delivery in vivo. Barcode sequences enable simultaneous evaluation of multiple nucleic acid nanocarriers in a single test organism for in vivo biodistribution as well as in vivo bioactivity.

Citing Articles

Effect of Different Karyophilic Peptides on Physical Characteristics and In Vitro Transfection Efficiency of Chitosan-Plasmid Nanoparticles as Nonviral Gene Delivery Systems.

Aranda-Barradas M, Coronado-Contreras H, Aguilar-Castaneda Y, Olivo-Escalante K, Gonzalez-Diaz F, Garcia-Tovar C Mol Biotechnol. 2024; 67(2):723-733.

PMID: 38400988 PMC: 11711767. DOI: 10.1007/s12033-024-01087-9.


Vibropolyfection: coupling polymer-mediated gene delivery to mechanical stimulation to enhance transfection of adherent cells.

Ponti F, Bono N, Russo L, Bigini P, Mantovani D, Candiani G J Nanobiotechnology. 2022; 20(1):363.

PMID: 35933375 PMC: 9356458. DOI: 10.1186/s12951-022-01571-x.


NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development.

Bashiri Dezfouli A, Yazdi M, Pockley A, Khosravi M, Kobold S, Wagner E Cells. 2021; 10(12).

PMID: 34943898 PMC: 8699535. DOI: 10.3390/cells10123390.


Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects.

Zu H, Gao D AAPS J. 2021; 23(4):78.

PMID: 34076797 PMC: 8171234. DOI: 10.1208/s12248-021-00608-7.

References
1.
Stein C, Castanotto D . FDA-Approved Oligonucleotide Therapies in 2017. Mol Ther. 2017; 25(5):1069-1075. PMC: 5417833. DOI: 10.1016/j.ymthe.2017.03.023. View

2.
Kang Y, Kwon K, Ryu J, Lee H, Park C, Chung H . Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance. Bioconjug Chem. 2017; 28(4):957-967. DOI: 10.1021/acs.bioconjchem.6b00676. View

3.
Scholz C, Kos P, Leclercq L, Jin X, Cottet H, Wagner E . Correlation of length of linear oligo(ethanamino) amides with gene transfer and cytotoxicity. ChemMedChem. 2014; 9(9):2104-10. DOI: 10.1002/cmdc.201300483. View

4.
Lachelt U, Wagner E . Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond). Chem Rev. 2015; 115(19):11043-78. DOI: 10.1021/cr5006793. View

5.
Lachelt U, Wittmann V, Muller K, Edinger D, Kos P, Hohn M . Synthetic polyglutamylation of dual-functional MTX ligands for enhanced combined cytotoxicity of poly(I:C) nanoplexes. Mol Pharm. 2014; 11(8):2631-9. DOI: 10.1021/mp500017u. View